Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1991-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JCEM-73-6-1309PMID 1955513
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunohistochemical detection of parathyroid hormone-related protein in human fetal epithelia.

  1991cited by this paper
• Measurement of parathyroid hormone-related protein in extracts of fetal parathyroid glands and placental membranes.

  1990cited by this paper
• Case records of the Massachusetts General Hospital.

  1990cited by this paper
• Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer.

  1990cited by this paper
• Tumor resection and antibodies to parathyroid hormone-related protein cause similar changes on bone histomorphometry in hypercalcemia of cancer.

  1990cited by this paper
• Hypercalcemia in pregnancy and lactation due to parathyroid hormone-related protein production

  1990cited by this paper
• Circulating concentrations of parathyroid hormone‐like peptide in malignancy and in hyperparathyroidism

  1990cited by this paper
• Breast Cancer-Associated Hypercalcaemia: A Reassessment of Renal Calcium and Phosphate Handling

  1990cited by this paper
• Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.

  1990cited by this paper
• Immunohistochemical localization of parathyroid hormone‐related protein in parathyroid adenoma and hyperplasia

  1990cited by this paper
• Isolation and characterization of the human parathyroid hormone-like peptide gene.

  1989cited by this paper
• Increased serum levels of a parathyroid hormone-like protein in malignancy-associated hypercalcemia.

  1989cited by this paper
• Actions of synthetic parathyroid hormone-related protein(1-34) on the isolated rat kidney.

  1989cited by this paper
• High levels of a parathyroid hormone-like protein in milk.

  1989cited by this paper
• Parathyroid hormone‐related protein: Immunohistochemical localization in cancers and in normal skin

  1989cited by this paper
• Purification and characterization of recombinant human parathyroid hormone-related protein.

  1989cited by this paper
• Structure of the 5' flanking region of the gene encoding human parathyroid-hormone-related protein (PTHrP).

  1989cited by this paper
• Comparison of postreceptor effects of 1-34 human hypercalcemia factor and 1-34 human parathyroid hormone in rat osteosarcoma cells.

  1988cited by this paper
• Antibodies to parathyroid hormone-related protein lower serum calcium in athymic mouse models of malignancy-associated hypercalcemia due to human tumors.

  1988cited by this paper
• Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy.

  1988cited by this paper
• Synthetic human parathyroid hormone-like protein stimulates bone resorption and causes hypercalcemia in rats.

  1988cited by this paper
• Expression of messenger ribonucleic acids encoding a parathyroid hormone-like peptide in normal human and animal tissues with abnormal expression in human parathyroid adenomas.

  1988cited by this paper
• Human renal carcinoma expresses two messages encoding a parathyroid hormone-like peptide: evidence for the alternative splicing of a single-copy gene.

  1988cited by this paper
• Expression of a calcium-mobilizing parathyroid hormone-like peptide in lactating mammary tissue.

  1988cited by this paper
• Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents.

  1988cited by this paper
• Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy.

  1987cited by this paper
• Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone.

  1987cited by this paper
• N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like and parathyroid hormone-unlike domains.

  1987cited by this paper
• A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression.

  1987cited by this paper
• Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo and in vitro.

  1987cited by this paper
• Parathyroid hormone-related protein of malignancy: active synthetic fragments.

  1987cited by this paper
• Parathyroid hormone-related protein purified from a human lung cancer cell line.

  1987cited by this paper
• Hypercalcemia in breast cancer. Reassessment of the mechanism.

  1987cited by this paper
• Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases.

  1985cited by this paper
• Mechanism of malignant hypercalcaemia in carcinoma of the breast.

  1985cited by this paper
• The hypercalcemia of malignancy: pathogenesis and management.

  1982cited by this paper
• Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.

  1980cited by this paper

• Désordres du métabolisme du calcium et du phosphate, en dehors de l’insuffisance rénale

  2025cites this paper
• Research Progress of Biomarkers Related to Bone Metastasis of Breast Cancer

  2024cites this paper
• PTHrP intracrine actions divergently influence breast cancer growth through p27 and LIFR

  2024cites this paper
• A Model-Based Approach to Diagnosing Hypercalcemia

  2023cites this paper
• Computed tomography density changes of bone metastases after concomitant denosumab

  2023cites this paper
• Abaloparatide prevents immobilization‐induced cortical but not trabecular bone loss after spinal cord injury

  2023cites this paper
• Bone Remodeling and Modeling: Cellular Targets for Antiresorptive and Anabolic Treatments, Including Approaches Through the Parathyroid Hormone (PTH)/PTH-Related Protein Pathway

  2023cites this paper
• Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases

  2022cites this paper
• Parathyroid hormone-related protein in breast cancer bone metastasis.

  2022cites this paper
• Role of parathyroid hormone-related protein in breast cancer detection and prognosis

  2022cites this paper
• Palliative care for patients with bone metastases

  2022cites this paper
• Parathyroid hormone-related protein

  2021cites this paper
• Rare Causes of Hypercalcemia: 2021 Update.

  2021cites this paper
• Physiological and Pharmacological Roles of PTH and PTHrP in Bone using their Shared Receptor, PTH1R.

  2021cites this paper
• Detection of hypokalemia disorder and its relation with hypercalcemia in blood serum using LIBS technique for patients of colorectal cancer grade I and grade II

  2021cites this paper
• Dmp1Cre‐directed knockdown of parathyroid hormone–related protein (PTHrP) in murine decidua is associated with a life‐long increase in bone mass, width, and strength in male progeny

  2021cites this paper
• Disorders of Divalent Ions (Magnesium, Calcium, and Phosphorous) in Patients With Cancer.

  2021cites this paper
• Parathyroid hormone-related peptide and other mediators of skeletal manifestations of malignancy

  2020cites this paper
• Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift

  2020cites this paper
• Immune checkpoint inhibitor-associated hypercalcaemia.

  2020cites this paper
• Your role in early diagnosis & Tx of metastatic bone disease.

  2020cites this paper
• Dmp1Cre-directed knockdown of PTHrP in murine decidua is associated with increased bone width and a life-long increase in strength specific to male progeny

  2020cites this paper
• Paracrine parathyroid hormone–related protein in bone: physiology and pharmacology

  2020cites this paper
• Brief exposure to full length Parathyroid Hormone-related Protein (PTHrP) causes persistent generation of cyclic AMP through an endocytosis-dependent mechanism.

  2019cites this paper
• Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and β‐arrestin recruitment than teriparatide

  2019cites this paper
• A computational study of the dual effect of intermittent and continuous administration of parathyroid hormone on bone remodeling.

  2019cites this paper
• Multiple actions of parathyroid hormone‐related protein in breast cancer bone metastasis

  2019cites this paper
• Autocrine and Paracrine Regulation of the Murine Skeleton by Osteocyte‐Derived Parathyroid Hormone‐Related Protein

  2018influential citation
• Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer

  2018cites this paper
• Hypercalcemia and cancer: Differential diagnosis and treatment

  2018cites this paper
• Hypercalcemia of malignancy treated with cinacalcet

  2017cites this paper
• Spine bone mineral density increases after 6 months of exclusive lactation, even in women who keep breastfeeding

  2017cites this paper
• Odontogenic Potential of Parathyroid Hormone‐related Protein (107–111) Alone or in Combination with Mineral Trioxide Aggregate in Human Dental Pulp Cells

  2017cites this paper
• Hypercalcaemia and hypocalcaemia: finding the balance

  2017cites this paper
• THERETO IN THE DAGNOSIS AND TREATMENT OF DISEASE

  2017cites this paper
• Parathyroid Hormone-Related Protein, Its Regulation of Cartilage and Bone Development, and Role in Treating Bone Diseases.

  2016cites this paper
• Désordres du métabolisme du calcium et du phosphate, en dehors de l’insuffisance rénale

  2016cites this paper
• Treatment of osseous metastases using the Spinal Tumor Ablation with Radiofrequency (STAR) system

  2016cites this paper
• Approach to Hypercalcemia

  2016cites this paper
• Chapter 6 – Intracellular Calcium

  2016cites this paper
• Hypercalcémies extraparathyroïdiennes

  2015cites this paper
• Traitements inhibiteurs de la résorption osseuse en situation métastatique : bilan actuel et perspectives

  2015cites this paper
• Interactions of PTHrP with Receptors and Signaling

  2015cites this paper
• Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases

  2015cites this paper
• Current scenario of biomarkers in head and neck cancer

  2015cites this paper
• Nanochannel array device operating through Prussian blue nanoparticles for sensitive label-free immunodetection of a cancer biomarker.

  2015cites this paper
• Hypercalcemia Due to PTHrP

  2015cites this paper
• Endocrine Paraneoplastic Syndromes: A Review

  2015cites this paper
• The Role of PTHrP in Regulating Mineral Metabolism During Pregnancy, Lactation, and Fetal/Neonatal Development

  2014influential citation
• Study and development of new biosensors based on nanoparticles and nanochannels

  2014cites this paper
• Obtusifolin suppresses phthalate esters-induced breast cancer bone metastasis by targeting parathyroid hormone-related protein.

  2014cites this paper
• Electrolyte disorders associated with cancer.

  2014cites this paper
• The Role of PTHrP in Skeletal Metastases and Hypercalcemia of Malignancy

  2014cites this paper
• A control engineering model of calcium regulation.

  2014cites this paper
• Integrating Endocrine and Paracrine Influences on Bone; Lessons From Parathyroid Hormone and Parathyroid Hormone-Related Protein

  2013cites this paper
• RANKL, a necessary chance for clinical application to osteoporosis and cancer-related bone diseases.

  2013cites this paper
• Conversations with pioneers in the bone field :

  2013cites this paper
• Conversations with pioneers in the bone field: T. John Martin

  2013cites this paper
• Acute kidney injury, sodium disorders, and hypercalcemia in the aging kidney: diagnostic and therapeutic management strategies in emergency medicine.

  2013cites this paper
• Endocrine cancerEndocrine manifestations of malignancy

  2013cites this paper
• Chapter 4 – Integrating Endocrine and Paracrine Influences on Bone: Lessons from Parathyroid Hormone and Parathyroid Hormone-related Protein

  2013cites this paper
• Non-malignant causes of hypercalcemia in cancer patients: a frequent and neglected occurrence

  2013cites this paper
• Hypercalcemia of malignancy

  2013cites this paper
• Calcium sensing receptor modulation for cancer therapy.

  2012cites this paper
• The role of bone microenvironment, vitamin D and calcium.

  2012cites this paper
• Disorders of Calcium, Magnesium, and Phosphate Balance

  2012cites this paper
• Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia.

  2012cites this paper
• Twenty‐five years of PTHrP progress: From cancer hormone to multifunctional cytokine

  2012influential citation
• The role of the calcium-sensing receptor in human disease.

  2012cites this paper
• Mechanisms and treatment of hypercalcemia of malignancy

  2011cites this paper
• Establishment of a new murine model of hypercalcemia with anorexia by overexpression of soluble receptor activator of NF-κB ligand using an adenovirus vector

  2011cites this paper
• End‐of‐Life Decision Making

  2011cites this paper
• Bone metastases, general and clinical issues.

  2011cites this paper
• Parathyroid Hormone Related Protein: A Marker of Breast Tumor Progression and Outcome

  2011cites this paper
• Padecimientos sistémicos que afectan el metabolismo óseo

  2010cites this paper
• Parathyroid hormone regulates fetal‐placental mineral homeostasis

  2010cites this paper
• Bisphosphonates, Bone Health and the Clinical Biology of Bone Metastases from Breast Cancer

  2010cites this paper
• Management of Parathyroid Disorders

  2010cites this paper
• Mechanistic Role of RANKL in Cancer-induced Bone Diseases and Development of a Targeted Therapy to Inhibit this Pathway

  2010cites this paper
• Evaluation of hypercalcemia in relation to hyperparathyroidism.

  2010cites this paper
• Endocrine manifestations of malignancy

  2009cites this paper
• Intravenous aminobisphosphonates for managing complications of malignant osteolysis in companion animals.

  2009cites this paper
• The role of the calcium-sensing receptor in the development and progression of cancer.

  2009cites this paper
• Chapter 15 – Hypercalcemia of Malignancy

  2009cites this paper
• Extracellular calcium promotes the migration of breast cancer cells through the activation of the calcium sensing receptor.

  2009cites this paper
• Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy.

  2009cites this paper
• Sindromi ipercalcemiche non paratiroidee

  2009cites this paper
• Surgical management of metastatic bone disease.

  2009cites this paper
• Medical treatment of malignancy-associated hypercalcemia.

  2008cites this paper
• Role of calcium-sensing receptor in bone biology.

  2008cites this paper
• BMP‐2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells

  2008cites this paper
• Parathyroid Hormone-Related Peptide and Other Systemic Factors in Skeletal Manifestations of Malignancy

  2008cites this paper
• Special Clinical Situations in Patients with Breast Cancer

  2008cites this paper
• Effects of uteroplacental insufficiency and reducing litter size on maternal mammary function and postnatal offspring growth.

  2008cites this paper
• Drugs for hypercalcemia

  2008cites this paper
• Clinical value of bisphosphonates in cancer therapy.

  2007cites this paper
• Effect of high oxygen on placental function in short-term explant cultures

  2007cites this paper
• Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.

  2007influential citation
• The role of bisphosphonates in the management of patients that have cancer.

  2007cites this paper
• Skeletal metastasis: Established and emerging roles of parathyroid hormone related protein (PTHrP)

  2007cites this paper